FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures Pittsburgh Post Gazette Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC BPC 157: Miracle Healing Peptide or Hidden Danger? FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Most people hear not FDA approved and immediately think unsafe or ineffective but the reality is a lot more about economics than science. If something can't be patented, there's little incentive to